Nov 2023: Pasi peProjekti Renewal, chirongwa cheOncology Center of Excellence (OCE) chakanangana nekuvandudza ruzivo rwemazita emishonga yechikuru yeoncology kuti ive nechokwadi chekuti ruzivo rwune chinangwa chekiriniki uye nesainzi, iyo Food and Drug Administration (FDA) yakabvumidza yakagadziridzwa label ye temozolomide. Temodar, Merck). Pasi pechirongwa chekuyedza ichi, uyu ndiwo mushonga wechipiri kuti zita rawo rivandudzwe. Capecitabine (Xeloda) ndiyo yaive yekutanga mishonga yakabvumidzwa pasi peProjekti Renewal.
Kuburikidza nekuedza kwakabatana kweProjekti Renewal, masayendisiti ekutanga-basa uye nyanzvi dzekunze oncology vanoongorora zvinyorwa zvakaburitswa kuti vazviwanire ruzivo rwekutanga mukusarudza, curation, uye kuongororwa kwedata rekuzvimiririra FDA ongororo. Chinangwa cheProjekti Renewal ndechekuchengetedza mazita achangoburwa emishonga yeoncology yevakuru, inogara ichitaurwa, uchiwedzera ruzivo rweveruzhinji rwekunyorwa kwezvinodhaka sesosi yeruzivo uye kupa pachena pane zvinodikanwa zveuchapupu zveFDA uye maitiro ekuongorora.
Temozolomide ikozvino yatenderwa kune inotevera uye yakadzokororwa zviratidzo:
- adjuvant kurapwa kwevakuru vane achangobva kuongororwa anaplastic astrocytoma.
- kurapwa kwevanhu vakuru vane refractory anaplastic astrocytoma.
Imwe chiratidzo chakatenderwa che temozolomide chinoramba chakafanana:
- kurapwa kwevakuru vane ichangobva kuwanikwa glioblastoma, pamwe chete neradiotherapy uyezve sekurapa kwekuchengetedza.
Kuwedzera kudzokororwa kwemazita kunosanganisira:
- Iyo dosage regimen inodzokororwa uye kuvandudzwa kune ichangobva kuongororwa glioblastoma uye refractory anaplastic astrocytoma.
- Kune Temodar capsules, ruzivo pamusoro penjodzi kubva kune yakavhurika capsules inowedzerwa pasi peYambiro uye Chengetedzo.
- Chikamu cheRuzivo rweKurayira Kwevarwere uye gwaro reRuzivo rweMurwere zvinogadziridzwa nekudzokororwa.
